Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Cardiology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
EMJ Cardiology 11.1 2023
October 2023
Explore a unique selection of peer-reviewed articles, exclusive interviews with leading experts, and a comprehensive review of the ESC Congress…
Read more
September 2022
EMJ Cardiology 10 [Supplement 5] 2022
Highlighting a presentation that took place as part of the European Society of Cardiology’s (ESC) Heart Failure 2022 congress, this article summarised data on the efficacy and safety of aficamten in patients with symptomatic obstructive hypertrophic cardiomyopathy (HCM).
August 2022
EMJ Cardiology 10 [Supplement 4] 2022
Speaking at the European Society of Cardiology (ESC) Congress 2021, Gabriel Steg and Kausik Ray discussed the residual risk of recurrent cardiovascular (CV) events that remains despite optimal standards of care for secondary prevention in the 90-day high-risk period after an acute myocardial infarction (AMI).
July 2022
EMJ Cardiology 10 [Supplement 3] 2022
This article summarises the groundbreaking research and personalised approach to atherosclerotic cardiovascular disease…
July 2022
EMJ Cardiology 10 [Supplement 2] 2022
EMJ had the pleasure of interviewing leading specialists within the field of cardiology and electrophysiology, Bruno Schwagten, ZNA Middelheim, Antwerp, Belgium, and Yurii Deminskyi…
June 2022
EMJ Cardiology 10 [Supplement 1] 2022
A leading expert from the field of cardiology and cardiovascular disease provided their perspectives on Phase II data and the design…
December 2021
EMJ Cardiology 9 [Supplement 3] 2021
CARDIOVASCULAR magnetic resonance (CMR) has emerged as a promising technique for measuring coronary artery disease (CAD) and an alternative…
October 2021
EMJ Cardiology 9.1 2021
Welcome to the latest issue of EMJ Cardiology! We are proud to share with you an impressive collection of novel and interesting research, alongside our independent review of the European Society of Cardiology (ESC) Congress 2021, with abstract summaries and late-breaking news from the virtual event.
March 2021
EMJ Cardiology 9 [Supplement 2] 2021
The proCardio event, a global Cardiac Biomarker Forum, was held virtually as a series of three webinars from 12th to 14th October 2020…
Loading posts...
« Previous
1
2
3
4
5
Next »